Clinical Reviews in Allergy & Immunology

, Volume 17, Issue 3, pp 361–381

Immunotherapy for food allergies

Past, present, future
  • Samuel B. Lehrer
  • Laurianne G. Wild
  • Kenneth L. Bost
  • Ricardo U. Sorensen
Food Sensitivity

Conclusion

The future certainly holds promise for the treatment of food allergies. Generally, future treatments can be divided into immunological manipulation of the food-allergic subject (mucosal vaccines, new immunotherapies, cytokine level alterations) or manipulation of the food through genetic engineering to diminish or abolish its allergenic activity.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Yocum MW, Khan DA. Assessment of patients who have experienced anaphylaxis: a three year survey. Mayo Clin Proc 1994;69:16–23.PubMedGoogle Scholar
  2. 2.
    Ellis MH, Short JA, Heiner DC. Anaphylaxis after ingestion of a recently introduced hydrolyzed whey protein formula. J Pediatr 1991;118:74–77.PubMedCrossRefGoogle Scholar
  3. 3.
    Saylor JD, Bahna SL. Anaphylaxis to casein hydrolysate formula. J Pediatr 1991; 118:71–74.PubMedCrossRefGoogle Scholar
  4. 4.
    Sampson HA, Mendelsoon IM, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992;327:380–384.PubMedCrossRefGoogle Scholar
  5. 5.
    Yunginger JW, Sweeney KG, Sturner WQ, et al. Fatal food-induced anaphylaxis. JAMA 1988;260:1450–1452.PubMedCrossRefGoogle Scholar
  6. 6.
    Bock SA. Natural history of severe reactions to foods in young children. J Pediatr 1985;107:676–680.PubMedCrossRefGoogle Scholar
  7. 7.
    Bock SS. The natural history of food sensitivity. J Allergy Clin Immunol 1982; 69:173–177.PubMedCrossRefGoogle Scholar
  8. 8.
    Hill DJ, Cameron DJS, Francis DEM, et al. Challenge confirmation of late-onset reactions to extensively hydrolyzed formulas in infants with multiple food protein intolerance. J Allergy Clin Immunol 1995;96:386–394.PubMedCrossRefGoogle Scholar
  9. 9.
    Metcalfe DD. Food allergy. In: Ogra PL, Lamm ME, McGhee JR, Mestecky J, Strober W, and Bienenstock J (eds). Handbook of Mucosal Immunology, 1st ed. New York: Academic, 1994, pp. 493–504.Google Scholar
  10. 10.
    Handbook of Mucosal Immunology, 2nd ed. Ogra P Lamm M, McGhee J, Mestecky J, Stober W, & Bienenstock eds), New York, Academic, 1998, in press.Google Scholar
  11. 11.
    Neutra MR, Kraehenbuhl JM, et al. Cells as a pathway for antigen uptake and processing. In: Kagnoff, M, Kiyono H (eds), Essentials of Mucosal Immunology. New York: Academic, 1996, pp. 513–542.Google Scholar
  12. 12.
    Kiyono H, McGee JR. T helper cells for mucosal immune responses. In: Handbook of Mucosal Immunology, 1st ed. Ogra P, Lamm M, McGhee J, Mestecky J, Strober W, & Bienenstock J (eds.), New York: Academic 1994, pp. 263–274.Google Scholar
  13. 13.
    Abreu-Martin MT, Targan SR. Lamina propria lymphocytes. in: Kagnoff M, Kiyono H (eds.), Essentials of Mucosal Immunology. New York: Academic, 1996, pp. 227–246.Google Scholar
  14. 14.
    Lefrancois L. Basic aspects of intraepithelial lymphocyte immunobiology. In: Handbook of Mucosal Immunology 1st ed. Ogra P, Lamm M, McGhee J, Mestecky J, Strober W, & J Bienenstock (eds.), New York: Academic, 1994, pp. 287–298.Google Scholar
  15. 15.
    Noon L, Cantab B. Prophylactic inoculation against hay fever. Lancet 1911; i:1572.CrossRefGoogle Scholar
  16. 16a.
    Freeman J. “Rush” inoculation, with special reference to hay fever treatment. Lancet 1930; I:744–747.CrossRefGoogle Scholar
  17. 16b.
    Nelson HS, Lahr J, Rule R, et al. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997;99:744–751.PubMedCrossRefGoogle Scholar
  18. 17.
    Oppenheimer JJ, Nelson HS, Bock SA, et al. Treatment of peanut allergy with rush immunotherapy. J. Allergy Clin Immunol 1992;90:256–262.PubMedCrossRefGoogle Scholar
  19. 18.
    Tomasi TB. Oral tolerance. Transplantation 1980; 29(5):353–355.PubMedCrossRefGoogle Scholar
  20. 19.
    Taudorf, E., Laursen LC, Lanner A, et al. Oral immunotherapy, in birch pollen hay fever. J Allergy Clin Immunol 1987;80:153–161.PubMedCrossRefGoogle Scholar
  21. 20.
    Van Deusen MA, Angelini BL, Cordoro KM, et al. Efficacy and safety of oral immunotherapy with short ragweed extract. Ann Allergy Asthma Immunol 1997;78:573–580.PubMedGoogle Scholar
  22. 21.
    Machiels JJ, Somville MA, Jacquemin MG, et al. Allergen-antibody complexes can efficiently prevent seasonal allergic rhinitis and asthma in grass pollen hypersensitive patients. Allergy 1991;46:335–348.PubMedCrossRefGoogle Scholar
  23. 22.
    Machiels JJ, Somville MA, Lebrun PM, et al. Allergic bronchial asthma due to dermatophygoides pteronyssinus hypersensitivity can be efficiently treated by inoculation of allergen-antibody complexes. J Clin Invest 1990;85:1024–1035.PubMedGoogle Scholar
  24. 23.
    Briner TJ, Kuo MC, Keating KM, et al. Peripheral T-cell tolerance induced in naive andprimed mice by subcutaneous injection of peptides from the major cat allergen Fel d 1. Proc Natl Acad Sci USA 1993;90:7608–7612.PubMedCrossRefGoogle Scholar
  25. 24.
    Norman PS, Ohman JL Jr, Long AA, et al. Treatment of cat allergy with T-cell reactive peptides. Am J Respir Crit Care Med 1996;154:1623–1628.PubMedGoogle Scholar
  26. 25.
    Casale TB, Bernstein IL, Busse WW, et al. use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1997;100:110–121.PubMedCrossRefGoogle Scholar
  27. 26.
    Saban R. Human Fier1-IgG and humanized anti-IgE monoclonal antibody MaE11 block passive sensitizer of human and Rhesus monkey lung. Allergy Clin Immunol 1994;94:836–843.CrossRefGoogle Scholar
  28. 27.
    Shields RL, et al. Inhibition of allergic reactions with antibodies to IgE. Int Arch Allergy Immunol 1995;105:308–312.CrossRefGoogle Scholar
  29. 28.
    Boulet LP, Chapman KR, Cote J, et al. Inhibitory effects of an Anti-IgE antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med 1997;155:1835–1840.PubMedGoogle Scholar
  30. 29.
    Fahy JV, Fleming HE, Wong HH, et al. The effect of an Anti-IgE monoclonal antibody on the early-and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 1997;155:1828–1834.PubMedGoogle Scholar
  31. 30.
    MacGlashan DW Jr, Bochner BS, Adelman DC, et al. Down-regulation of FCεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997;158:1438–1445.PubMedGoogle Scholar
  32. 31.
    Goodman JS, Van Uden JH, Kobayashi H, et al. DNA immunotherapeutics: New Potential treatment modalities for allergic disease. Int Arch Allergy Immunol 1998; 116:177–187.PubMedCrossRefGoogle Scholar
  33. 32.
    Spiegelberg HL, Orozco EM, Roman M, et al. DNA Immunization: a novel approach to allergen-specific immunotherapy. Allergy 1997;52:964–970.PubMedCrossRefGoogle Scholar
  34. 33.
    Slater JE, Zhang YJ, Arthur-Smith A, et al. A DNA vaccine inhibits IgE responses to the latex allergen Hev b 5 in mice. J Allergy Clin Immunol 1997; 99:S504.Google Scholar
  35. 34.
    Reese G, Carle T, Lehrer SB. Epitope characterization of the major shrimp allergen Pen A 1 (Tropomyosin). J Invest Med 1998; 46(1):48A.Google Scholar
  36. 35.
    Litwin A, Flanagan M, Entis G, et al. Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy. Ann Allergy Asthma Immunol 1996; 77:132–138.PubMedCrossRefGoogle Scholar
  37. 36.
    Takahashi I, Kiyono H, Marinaro M, et al. Mechanisms for mucosal immunogenicity and adjuancy of Escherichia coli labile enterotoxin. J Infect Dis 1996; 173:627–635.PubMedGoogle Scholar
  38. 37.
    Clements JD, Chong C, Bost KL. Use of attenuated Salmonella vectors for oral vaccines. In: Kagnoff, M, Kiyono, H (eds.). Essentials of Mucosal Immunology. New York: Academic, 1996, pp. 513–542.Google Scholar
  39. 38.
    Weiner HL. Oral tolerance for treatment of autoimmune disease. Ann Rev Med 1997; 48:341–351.PubMedCrossRefGoogle Scholar
  40. 39.
    Garside P, Mowat AM. Mechanisms of oral tolerance. Crit Rev Immunol 1997; 17:119–137.PubMedGoogle Scholar
  41. 40.
    King HC, King WP. Alternatives in the diagnosis and treatment of food allergies. Otolaryngol Clin North Am 1998; 31:141–156.PubMedCrossRefGoogle Scholar
  42. 41.
    Cleland JL. Protein delivery from biodegradable microspheres. Pharm Biotechnol 1997; 10:1–43.PubMedCrossRefGoogle Scholar
  43. 42.
    Astwood JD, Fuchs RL. Allergenicity of foods derived from transgenic plants. In: Wuthrich, B, Ortolani, C (eds.). Highlights in Food Allergy. Monogr Allergy Basel: Karger 1996, Vol. 32, pp. 105–120.Google Scholar
  44. 43.
    Harlander SK. Biotechnology—a means for improving our food supply. Food Technol 1991; 45(4):84.Google Scholar
  45. 44.
    Kessler DA, Taylor MR, Maryanski Jr H, et al. The safety of foods developed by biotechnology. Science 1992; 256:1747.PubMedCrossRefGoogle Scholar
  46. 45.
    Olempska-Beer ZS, Kuznesof PM, DiNovi M, et al. Plant biotechnology and food safety. Food Technol 1993; 47(12):64.Google Scholar
  47. 46.
    Matsuda T, Alvarez AM, Tada Y, et al. Gene engineering for hypo-allergenic rice: repression of allergenic protein synthesis in seeds of transgenic rice plants by antisense RNA. In: Proceedings of the International Workshop on Life Science in Production and Food-consumption of Agricultural Products Session-4. Tsukuba Japan: Tsukuba Center, 1993.Google Scholar
  48. 47.
    Matsuda T, Nakamura R. Molecular structure and immunologic properties of food allergens. Trends Food Sci Technol 1993; 4:289–293.CrossRefGoogle Scholar
  49. 48.
    Stanley JS, King N, Burks AW, et al. Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2. Arch Biochem Biophys 1997; 342(2):244–253.PubMedCrossRefGoogle Scholar
  50. 49.
    Astwood JD, Fuchs RL, Lavrik PB, et al. Food biotechnology and genetic engineering. In: Metcalfe, DD, Sampson, HA, Simon, RA (eds.), Food Allergy: Adverse Reactions to Foods and Food Additives. Cambridge, MA, Blackwell Science, 1997, pp. 65–92.Google Scholar
  51. 50.
    Businco L, Dreborg S, Einarsson R, et al. Hydrolysed cow’s milk formulae. Allergenicity and use in treatment and prevention. An ESPACI position paper. Pediatr Allergy Immunol 1993; 4:101–111.PubMedCrossRefGoogle Scholar
  52. 51.
    Watanabe M. Hypoallergenic rice as a physiologically functional food. Trends Foods Sci Technol 1993; 4:125–128.CrossRefGoogle Scholar
  53. 52.
    Ayuso R, Reese G, Tanaka L, Ibanez MD, et al. IgE antibody response to raw and cooked meats proteins in suspected meat-sensitive patients. J Invest Med 1998; 46(1):49A.Google Scholar
  54. 53.
    Lehrer SB, Reese G. Food allergens: implications for biotechnology. In: Biotechnology and Safety Assessment, 2nd ed., in press.Google Scholar
  55. 54.
    Adachi T, Izumi H, Yamada T, et al. Gene structure and expression of rice seed allergenic proteins belonging to the α-amylase/trypsin inhibitor family. Plant Mol Biol 1993; 21:239–248.PubMedCrossRefGoogle Scholar
  56. 55a.
    Lehrer SB, Taylor S, Hefle S, et al. Food allergens. In: Kay AB (ed.). Allergy and Allergic Diseases. London, UK: Blackwell Scientific Publications, 1997, pp. 961–980.Google Scholar
  57. 55b.
    Burks AW, Shin D, Cockrell G, et al. Mapping and mutational analysis of the IgE binding epitopes on Ara h 1, a legume vicilin protein and a major allergen in peanut hypersensitivity. Eur J Biol 1997; 245:334–339.CrossRefGoogle Scholar
  58. 56.
    Elsayed S, Apold J, Holen E, et al. The structural requirements of epitopes with IgE binding capacity demonstrated by three major allergens from fish, egg and tree pollen. Scand J Clin Lab Invest Supp., 204, 17, 1991.Google Scholar
  59. 57.
    Shanti KN, Martin BM, Nagpal S, et al. Identification of tropomyosin as the major shrimp allergen and characterization of its IgE binding epitopes. J Immunol 1993; 151:5354–5363.PubMedGoogle Scholar
  60. 58.
    Johnson G, Elsayed S. Antigenic and allergenic determinants of ovalbumin. III. MHC la-binding peptide (OA 323-229) interacts with human and rabbit specific antibodies. Mol Immunol 1990; 27:821–827.CrossRefGoogle Scholar
  61. 59.
    Leung PSC, Chu KH, Chaw WK, et al. Cloning, expression, and primary structure of Metapenaeus enis tropomyosin, the major heat stable shrimp allergen. J Allergy Clin Immunol 1994; 92:837–845.Google Scholar
  62. 60.
    Burks AW, Williams LW, Connaughton C, et al. Identification and characterization of a second major peanut allergen, Ara h II with use of the sera of patients with atopic dermatitis and positive peanut challenge. J Allergy Clin Immunol 1992; 900:962–969.CrossRefGoogle Scholar
  63. 61.
    Burks AW, Williams LW, Helm RM, et al. Identification of a major peanut allergen, Ara h I, in patients with topic dermatitis and positive peanut challenges. J Allergy Clin Immunol 1991; 88:172–179.PubMedCrossRefGoogle Scholar
  64. 62.
    Burks AW, King M, Sampson H, et al. Modification of a major peanut allergen leads to loss of IgE binding. Int Arch Allergy (Abstract), 1998.Google Scholar
  65. 63a.
    Daul CB, Slattery M, Reese G, et al. Identification of the major brown shrimp (Penaeus aztecus) as the muscle protein tropomyosin. Int Arch Allergy Clin Immunol 1994; 105:49–55.Google Scholar
  66. 63b.
    Reese G, Ayuso R, Carle T, et al. IgE binding epitopes of shrimp tropomyosin, the major allergen Pen a 1. Int Arch Allergy Clin Immunol, in press.Google Scholar
  67. 64.
    Alderson MR, Armitage RJ, Tough TW, et al. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 1993;178.Google Scholar
  68. 65.
    Constant SL, Bottomly K. Induction of TH1 and TH2 CD4+ t cell responses: alternative approaches. Annu Rev Immunol 1997; 15:297–322.PubMedCrossRefGoogle Scholar

Copyright information

© Human Press Inc 1999

Authors and Affiliations

  • Samuel B. Lehrer
    • 1
  • Laurianne G. Wild
    • 1
  • Kenneth L. Bost
    • 2
  • Ricardo U. Sorensen
    • 3
  1. 1.Division of Allergy and Clinical Immunology, Department of MedicineTulane University Medical CenterNew Orleans
  2. 2.Department of BiologyUniversity of North Carolina at CharlotteCharlotte
  3. 3.Division of Allergy and Immunology, Department of PediatricsLouisiana State University Medical CenterNew Orleans

Personalised recommendations